The state of the art in the pathogenesis of ATL and new potential targets associated with HTLV-1 and ATL. (Q37008645)

17 August 2017

1 reference

title

The state of the art in the pathogenesis of ATL and new potential targets associated with HTLV-1 and ATL. (English)

1 reference

Human T-lymphotropic virus 1

17 August 2017

0 references

0 references

author name string

Ken Murata

series ordinal

1

1 reference

PubMed ID

18027200

17 August 2017

Yasuaki Yamada

series ordinal

2

1 reference

17 August 2017

1 September 2007

1 reference

International Reviews of Immunology

17 August 2017

1 reference

17 August 2017

26

1 reference

17 August 2017

5-6

1 reference

17 August 2017

249-268

1 reference

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

17 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

The current status of therapy for adult T-cell leukaemia-lymphoma in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Molecular mechanisms of cellular transformation by HTLV-1 Tax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Activation of NF-kappaB by HTLV-I and implications for cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Segregation of NF-kappaB activation through NEMO/IKKgamma by Tax and TNFalpha: implications for stimulus-specific interruption of oncogenic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

HTLV-I Tax directly binds the Cdc20-associated anaphase-promoting complex and activates it ahead of schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

HBZ, a new important player in the mystery of adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

HBZ interacts with JunD and stimulates its transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

To cycle or not to cycle: a critical decision in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

The RB and p53 pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Regulation of p53 downstream genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Interruption of p16 gene expression in adult T-cell leukaemia/lymphoma: clinical correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Rapid Tumor Formation of Human T-Cell Leukemia Virus Type 1-Infected Cell Lines in Novel NOD-SCID/γcnullMice: Suppression by an Inhibitor against NF-κB

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Inhibition of tumor necrosis factor-alpha -induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Apo2L/TRAIL and its death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Sensitivity of adult T-cell leukaemia lymphoma cells to tumour necrosis factor-related apoptosis-inducing ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 product

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180701709817

10.1080/08830180701709817

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18027200